463 related articles for article (PubMed ID: 21322180)
1. The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
Clarke A; Scarth J; Teale P; Pearce C; Hillyer L
Drug Test Anal; 2011 Jan; 3(1):74-87. PubMed ID: 21322180
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control.
Scarth JP; Clarke AD; Teale P; Pearce CM
Steroids; 2010 Oct; 75(10):643-52. PubMed ID: 20381511
[TBL] [Abstract][Full Text] [Related]
3. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
4. The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine.
Scarth JP; Spencer HA; Hudson SC; Teale P; Gray BP; Hillyer LL
Steroids; 2010 Jan; 75(1):57-69. PubMed ID: 19854209
[TBL] [Abstract][Full Text] [Related]
5. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Kwok KY; Choi TLS; Kwok WH; Wong JKY; Wan TSM
J Chromatogr A; 2017 Apr; 1493():76-86. PubMed ID: 28314523
[TBL] [Abstract][Full Text] [Related]
6. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.
Cawley AT; Blakey K; Waller CC; McLeod MD; Boyd S; Heather A; McGrath KC; Handelsman DJ; Willis AC
Drug Test Anal; 2016 Jul; 8(7):621-32. PubMed ID: 27443417
[TBL] [Abstract][Full Text] [Related]
7. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
McKinney AR
Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
[TBL] [Abstract][Full Text] [Related]
8. Metabolic studies of oxyguno in horses.
Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
Anal Chim Acta; 2015 Sep; 891():190-202. PubMed ID: 26388378
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo metabolism of the anabolic-androgenic steroid oxandrolone in the horse.
Harding C; Viljanto M; Cutler C; Habershon-Butcher J; Biddle S; Scarth J
Drug Test Anal; 2022 Jan; 14(1):39-55. PubMed ID: 34378336
[TBL] [Abstract][Full Text] [Related]
10. The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance.
Scarth JP; Spencer HA; Timbers SE; Hudson SC; Hillyer LL
Drug Test Anal; 2010 Jan; 2(1):1-10. PubMed ID: 20878880
[TBL] [Abstract][Full Text] [Related]
11. In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse.
Waller CC; Weththasinghe SA; McClure L; Cawley AT; Suann C; Suann E; Sutherland E; Cooper E; Heather A; McLeod MD
Drug Test Anal; 2020 Jun; 12(6):752-762. PubMed ID: 31950580
[TBL] [Abstract][Full Text] [Related]
12. Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography-tandem mass spectrometry with instant library searching.
Liu Y; Uboh CE; Soma LR; Li X; Guan F; You Y; Rudy JA; Chen JW
Drug Test Anal; 2011 Jan; 3(1):54-67. PubMed ID: 20878876
[TBL] [Abstract][Full Text] [Related]
13. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
Sobolevsky T; Rodchenkov G
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of anabolic steroids and their relevance to drug detection in horseracing.
Teale P; Houghton E
Bioanalysis; 2010 Jun; 2(6):1085-107. PubMed ID: 21083210
[TBL] [Abstract][Full Text] [Related]
15. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
16. Drug metabolism in the horse: a review.
Scarth JP; Teale P; Kuuranne T
Drug Test Anal; 2011 Jan; 3(1):19-53. PubMed ID: 20967889
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism study of a black market product containing SARM LGD-4033.
Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
[TBL] [Abstract][Full Text] [Related]
19. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of the REV-ERB agonist SR-9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples.
Cutler C; White DL; Viljanto M
Drug Test Anal; 2022 Jan; 14(1):169-174. PubMed ID: 34224639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
